My Pitch: "http://www.barchart.com/charts/stocks/AIS VOL ALERT CHART NEWS 2.60 0.08 (+3.17%)Fri, Jul 22nd, 2011"

My Pitch: "Target 12.5$ TSL 9.08$
Holding till MTX launch
Testesterone results in January
20mg stuff"

My Pitch: "Future"

My Pitch: "Anturol targets a growing market for overactive bladder syndrome (OAB). In 2009, the US OAB market was 2.1 billion USD. This US market is expected to increase to more than 2.3 billion USD in 2014. In the United States, it is estimates that more than 34-million men and women are affected by OAB."

My Pitch: "Antares"

My Pitch: "increasing revenues; partners with big pharma; zero debt; focuses on generic self-injectors with fda approved drugs"

My Pitch: "Great future
"

My Pitch: "thanks lokodaug... see, you do get some props!"

My Pitch: "BULL in a China shop."

My Pitch: "Ais"

My Pitch: "
"

My Pitch: "
"

My Pitch: "8.18"

My Pitch: "Atrs"

My Pitch: "Big believer in the growth plan in place,my largest stock holding."

My Pitch: "Antares Pharm owns worldwide rights to BioSantes' LibiGel, the female equivalent of Pfizer's Viagra. In addition, they have recently submitted a SPA NDA on Anturol for the treatment of overactive bladder. Anturol is anticipated to be approved by 4th Q 2011. This is a $2 billion market in itself."

My Pitch: "Promising option"

My Pitch: "Y"